148 related articles for article (PubMed ID: 2154985)
1. Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes.
Kainoh M; Imai R; Umetsu T; Hattori M; Nishio S
Biochem Pharmacol; 1990 Feb; 39(3):477-84. PubMed ID: 2154985
[TBL] [Abstract][Full Text] [Related]
2. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
Fantone JC; Marasco WA; Elgas LJ; Ward PA
Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
[TBL] [Abstract][Full Text] [Related]
3. PGI2 analogue, sodium beraprost, suppresses superoxide generation in human neutrophils by inhibiting p47phox phosphorylation.
Okuyama M; Kambayashi J; Sakon M; Kawasaki T; Monden M
Life Sci; 1995; 57(11):1051-9. PubMed ID: 7658912
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
Armstrong RA
Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
[TBL] [Abstract][Full Text] [Related]
5. The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine.
Gryglewski RJ; Szczeklik A; Wandzilak M
Biochem Pharmacol; 1987 Dec; 36(24):4209-13. PubMed ID: 2446631
[TBL] [Abstract][Full Text] [Related]
6. Aroclor 1242 stimulates the production of inositol phosphates in polymorphonuclear neutrophils.
Tithof PK; Contreras ML; Ganey PE
Toxicol Appl Pharmacol; 1995 Mar; 131(1):136-43. PubMed ID: 7878669
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2.
Hecker G; Ney P; Schrör K
Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):308-15. PubMed ID: 2159112
[TBL] [Abstract][Full Text] [Related]
8. Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-phenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera.
Samuelsson J; Hansson A; Rosendahl K; Palmblad J
J Lab Clin Med; 1993 Feb; 121(2):310-9. PubMed ID: 8381848
[TBL] [Abstract][Full Text] [Related]
9. Dopamine inhibition of superoxide anion production by polymorphonuclear leukocytes.
Yamazaki M; Matsuoka T; Yasui K; Komiyama A; Akabane T
J Allergy Clin Immunol; 1989 May; 83(5):967-72. PubMed ID: 2541191
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde.
Wang JP; Chang LC; Lin YL; Hsu MF; Chang CY; Huang LJ; Kuo SC
Biochem Pharmacol; 2003 Apr; 65(7):1043-51. PubMed ID: 12663040
[TBL] [Abstract][Full Text] [Related]
11. Effects of FMLP and LPS on [Ca2+]i of peritoneal exudate polymorphonuclear leukocytes following onset of inflammation.
Qu J; Hosoi K; Shimojima T; Oi T; Ikeda K
J Periodontal Res; 1995 May; 30(3):153-8. PubMed ID: 7472996
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostacyclin analogs on cyclic adenosine monophosphate and superoxide formation in human polymorphonuclear leukocytes stimulated by formyl-methionyl-leucyl-phenylalanine.
Stahlberg HJ; Loschen G; Flohé L
Biol Chem Hoppe Seyler; 1988 May; 369(5):329-36. PubMed ID: 2844208
[TBL] [Abstract][Full Text] [Related]
13. Enamel matrix derivative promotes superoxide production and chemotaxis but reduces matrix metalloproteinase-8 expression by polymorphonuclear leukocytes.
Karima MM; Van Dyke TE
J Periodontol; 2012 Jun; 83(6):780-6. PubMed ID: 22050547
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes.
Villagrasa V; Navarrete C; Sanz C; Berto L; Perpiñá M; Cortijo J; Morcillo EJ
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):239-45. PubMed ID: 8803956
[TBL] [Abstract][Full Text] [Related]
15. Viscolin, a new chalcone from Viscum coloratum, inhibits human neutrophil superoxide anion and elastase release via a cAMP-dependent pathway.
Hwang TL; Leu YL; Kao SH; Tang MC; Chang HL
Free Radic Biol Med; 2006 Nov; 41(9):1433-41. PubMed ID: 17023270
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of circulating and exudated polymorphonuclear leukocytes in superoxide-generating response to cyclic AMP and cyclic AMP-elevating agents. Investigation of the underlying mechanism.
al-Essa LY; Niwa M; Kohno K; Nozaki M; Tsurumi K
Biochem Pharmacol; 1995 Jan; 49(3):315-22. PubMed ID: 7857318
[TBL] [Abstract][Full Text] [Related]
17. Enhancing and inhibitory effects of nitric oxide on superoxide anion generation in human polymorphonuclear leukocytes.
Morikawa M; Inoue M; Tokumaru S; Kogo H
Br J Pharmacol; 1995 Aug; 115(7):1302-6. PubMed ID: 7582560
[TBL] [Abstract][Full Text] [Related]
18. Altered free cytosolic calcium changes and neutrophil chemotaxis in patients with juvenile periodontitis.
Agarwal S; Reynolds MA; Duckett LD; Suzuki JB
J Periodontal Res; 1989 Mar; 24(2):149-54. PubMed ID: 2524580
[TBL] [Abstract][Full Text] [Related]
19. Splitomicin inhibits fMLP-induced superoxide anion production in human neutrophils by activate cAMP/PKA signaling inhibition of ERK pathway.
Liu FC; Day YJ; Liou JT; Yu HP; Liao HR
Eur J Pharmacol; 2012 Aug; 688(1-3):68-75. PubMed ID: 22634165
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP-elevating agents negatively regulate the activation of p72syk in N-formyl-methionyl-leucyl-phenylalanine receptor signaling.
Asahi M; Tanaka Y; Qin S; Tsubokawa M; Sada K; Minami Y; Yamamura H
Biochem Biophys Res Commun; 1995 Jul; 212(3):887-93. PubMed ID: 7626126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
